Medici List

Golden Minerals is an exploration-stage precious metals company (no operating mines) focused on advancing its Argentine Sarita Este and Desierto projects and the Sand Canyon project in Nevada via joint ventures and asset monetization, having divested most Mexican assets and facing liquidity/going-concern risk.

American Eagle Outfitters, Inc. is a public specialty apparel retailer and licensor operating brands including American Eagle and Aerie, selling direct-to-consumer through stores and digital channels with significant international licensing partnerships.

Applied Energetics, Inc. develops compact, fiber-based ultrashort-pulse laser and photonics systems for national security, biomedical, and advanced manufacturing applications.

Pre-revenue blank-check company (SPAC) with significant deferred offering costs and related-party promissory note financing; no reported revenues, accumulated deficit of $78,082, and total assets of $285,064 in the latest period.

Unnamed Cayman Islands SPAC holding approximately $348,366,162 in a trust account, with total assets of $349,248,591, total liabilities of $20,801,168 and an accumulated deficit of $19,920,235.

AmBase Corporation is a Delaware holding company that primarily manages its impaired equity investment in the 111 West 57th Street real estate development, holds mostly cash, reports no operating revenue, and relies on related-party loans and litigation funding while pursuing litigation and sale options to realize value.

TSOL is a Delaware statutory trust that issues shares trading on the Cboe BZX under the symbol TSOL, acting as a passive, ETF‑like vehicle to track the price of Solana (SOL) using the CME CF Solana‑Dollar Reference Rate and to reflect staking rewards net of fees.

Allurion develops and sells a metabolically focused weight‑loss platform centered on the Allurion Smart Capsule — a swallowable, procedureless intragastric balloon — paired with a digital care ecosystem (Allurion Virtual Care Suite, patient app, connected scale, and provider Insights dashboard) delivered via a B2B2C model across 50+ countries.

Specialty pharmaceutical company focused on infectious diseases, developing and commercializing therapies including Arakoda (tafenoquine) for malaria prevention and advancing programs in babesiosis, celgosivir/castanospermine extracts, and veterinary applications.

Clinical-stage precision-medicine pharmaceutical company developing stenoparib (a dual PARP1/2 and tankyrase inhibitor) and the DRP® companion diagnostic platform to identify patients most likely to benefit from targeted cancer therapies.

AEON Biopharma, Inc. is a SPAC-derived biopharmaceutical company developing ABP-450, a 900 kDa botulinum toxin biosimilar to Botox for therapeutic indications, relying on Daewoong for manufacturing and IP and with limited cash runway.

APHP is a publicly traded independent film co‑financier and co‑producer that develops, finances, and packages feature films and limited series, emphasizing structured film finance, IP acquisition, and selective strategic partnerships.